Coeptis Historical Income Statement
| COEP Stock | USD 0.20 0.01 5.26% |
Historical analysis of Coeptis Therapeutics income statement accounts such as Other Operating Expenses of 41.3 M, Total Operating Expenses of 41.3 M or Income Tax Expense of 4.1 M can show how well Coeptis Therapeutics performed in making a profits. Evaluating Coeptis Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Coeptis Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Coeptis Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Coeptis Therapeutics is a good buy for the upcoming year.
Coeptis |
About Coeptis Income Statement Analysis
Coeptis Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Coeptis Therapeutics shareholders. The income statement also shows Coeptis investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Coeptis Therapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Coeptis Therapeutics. It is also known as Coeptis Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Total Revenue
Total revenue comprises all receipts Coeptis Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most accounts from Coeptis Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Coeptis Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Coeptis Stock, please use our How to Invest in Coeptis Therapeutics guide.At this time, Coeptis Therapeutics' Other Operating Expenses is relatively stable compared to the past year. As of 11/30/2024, Total Operating Expenses is likely to grow to about 41.3 M, though EBIT is likely to grow to (35.5 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 14.1M | 34.2M | 39.3M | 41.3M | Depreciation And Amortization | 447.4K | 228.5K | 1.0M | 616.3K |
Coeptis Therapeutics income statement Correlations
Click cells to compare fundamentals
Coeptis Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Coeptis Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coeptis Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Coeptis Stock
| 0.57 | HLN | Haleon plc | PairCorr |
| 0.55 | ELAN | Elanco Animal Health | PairCorr |
| 0.51 | ZTS | Zoetis Inc | PairCorr |
| 0.44 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.41 | TAK | Takeda Pharmaceutical | PairCorr |
The ability to find closely correlated positions to Coeptis Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coeptis Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coeptis Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coeptis Therapeutics to buy it.
The correlation of Coeptis Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coeptis Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coeptis Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coeptis Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.